Clarus Lifesciences III, L.P.

Insider Reports History

Location
Cambridge, MA
Signature
CLARUS LIFESCIENCES III, L.P., By: Clarus Ventures III GP, L.P., its general partner, By: Blackstone Clarus III, L.L.C., its general partner, By: /s/ Omar Rehman, Name: Omar Rehman, Title: Chief Compliance Officer and Secretary
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Clarus Lifesciences III, L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Praxis Precision Medicines, Inc. 10%+ Owner Common Stock 4,894,109 $123,282,606 $25.19 12 May 2021 Indirect
Imago BioSciences, Inc. 10%+ Owner Common Stock 2,375,037 $85,501,332 $36.00 30 Mar 2022 Indirect
Tourmaline Bio, Inc. 10%+ Owner Common Stock 160,044 $2,720,748 $17.00 11 May 2021 Indirect
Tourmaline Bio, Inc. 10%+ Owner Series A-1 Convertible Preferred Stock 0 11 May 2021 Indirect
Tourmaline Bio, Inc. 10%+ Owner Series A Convertible Preferred Stock 0 11 May 2021 Indirect
Tourmaline Bio, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 11 May 2021 Indirect

Insider Reports Filed by Clarus Lifesciences III, L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000089924322013151-clarus-lifesciences-iii-l-p-2022-03-30 Imago BioSciences, Inc. 30 Mar 2022 1 $0 4 10%+ Owner 01 Apr 2022, 17:30
/report/000156761921013733-clarus-lifesciences-iii-l-p-2021-07-20 Imago BioSciences, Inc. 20 Jul 2021 7 +$2,400,000 4 10%+ Owner 20 Jul 2021, 18:05
/report/000156761921013523-clarus-lifesciences-iii-l-p-2021-07-15 Imago BioSciences, Inc. 15 Jul 2021 0 $0 3 10%+ Owner 15 Jul 2021, 17:45
PRAX Praxis Precision Medicines, Inc. 12 May 2021 1 $0 4 10%+ Owner 14 May 2021, 21:46
TRML Talaris Therapeutics, Inc. 11 May 2021 33 +$510,000 4 10%+ Owner 14 May 2021, 06:15